No luck needed. Several countries in Europe have been supplying it for several years hence the growing year-on-year profit and even some US insurance companies have actually been paying for patients to fly to Europe to get the implant despite it not being approved in the USA until 2 days ago.
News: CUV Clinuvel says U.S. pricing of rare disorder drug will not top European levels, page-3
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.65 |
Change
0.020(0.15%) |
Mkt cap ! $692.3M | |||
| Open | High | Low | Value | Volume |
| $13.63 | $13.94 | $13.59 | $247.4K | 17.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 251 | $13.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.68 | 29 | 3 |
View Market Depth
| Last trade - 12.18pm 13/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |